NNovo Nordisk Read More Heart drug flops raise doubts about high-tech approaches to pharma2026-11-09 The next time someone tells you that artificial intelligence, or any other new technology, is going to cure…
NNovo Nordisk Read More AHA conference news: Novo Nordisk’s ZEUS trial failure examined2026-11-07 CHICAGO — Out-of-control inflammation is often called the root of all evil in cardiovascular and metabolic disease. Recent…
NNovo Nordisk Read More Pharmalittle: Novo bid to block Lilly ad rejected, big PBMs probed2026-10-27 Rise and shine, everyone, another busy day is on the way. And it is getting off to a…
NNovo Nordisk Read More From obesity medicine to lifestyle drug: GLP-1 marketing shift explored2026-09-29 Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
NNovo Nordisk Read More PHarmalittle: FDA nominee grilled, Novo licenses drug delivery tech2026-09-25 And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
DDSV Read More DSV opens Incheon hub to fortify global healthcare supply chains2026-09-24 Global biomanufacturing has experienced a major shift towards East Asia, with South Korea emerging as an undeniable heavyweight…
DDSV Read More DSV opens Incheon hub to fortify global healthcare supply chains2026-09-22 Global biomanufacturing has experienced a major shift towards East Asia, with South Korea emerging as an undeniable heavyweight…
NNovo Nordisk Read More Pharmalittle: Novo expanding pipeline, Alkermes reports ADHD data2026-09-21 Hello there and welcome to a new week. STAT reporter Andrew Joseph here in London filling in for…
NNovo Nordisk Read More Novo details new strategy in obesity, other disease areas2026-09-21 Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
NNovo Nordisk Read More Novo Nordisk rebrands as ‘Novo,’ part of a culture shift2026-09-14 Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
NNovo Nordisk Read More Novartis, Novo Nordisk drug flops will likely ‘pop a hole in the balloon’ of field2026-09-11 Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of…
NNovo Nordisk Read More Pharmalittle: Second Novartis trial fails; Novo stops heart trials2026-09-08 Good morning, everyone, and welcome to another working week. We hope the weekend respite — longer than usual…